REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

Recruiting now

Conditions studied: Acute Ischemic Stroke

In brief

Post-Market Registry

Key facts

Study ID

NCT07599904

Run by

Medtronic Neurovascular Clinical Affairs

People needed

1500

Starts

2026-07-13

Expected to finish

2031-07-01

Last updated by the study team

2026-07-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements.
• Participant is treated or intended to be treated with a commercially available Medtronic Neurovascular device* during treatment for acute ischemic stroke.
• Participant is 18 years of age or older.

You may not qualify if…

• Participant who may be unable to complete follow-up within the registry.
• Participant of child-bearing potential who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
• Participant is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results based on Principal Investigator's discretion.

Where it is running

• McLaren Flint Hospital — Flint, Michigan, United States (enrolling)
• Buffalo General Medical Center — Buffalo, New York, United States (enrolling)
• University of Texas Health Science Center at Houston — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.